These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32107181)

  • 1. Chylomicronemia syndrome: Familial or not?
    Warden BA; Minnier J; Duell PB; Fazio S; Shapiro MD
    J Clin Lipidol; 2020; 14(2):201-206. PubMed ID: 32107181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.
    Paquette M; Amyot J; Fantino M; Baass A; Bernard S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3473-e3482. PubMed ID: 34019660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study.
    Rodriguez FH; Estrada JM; Quintero HMA; Nogueira JP; Porras-Hurtado GL
    Lipids Health Dis; 2023 Mar; 22(1):43. PubMed ID: 36978188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia.
    Paquette M; Bernard S; Hegele RA; Baass A
    Atherosclerosis; 2019 Apr; 283():137-142. PubMed ID: 30655019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease in patients with chylomicronemia syndromes.
    De Villers-Lacasse A; Paquette M; Baass A; Bernard S
    J Clin Lipidol; 2023; 17(4):475-482. PubMed ID: 37258405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes.
    D'Erasmo L; Di Costanzo A; Cassandra F; Minicocci I; Polito L; Montali A; Ceci F; Arca M
    Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2531-2541. PubMed ID: 31619059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10-Year Comparative Follow-up of Familial versus Multifactorial Chylomicronemia Syndromes.
    Belhassen M; Van Ganse E; Nolin M; Bérard M; Bada H; Bruckert E; Krempf M; Rebours V; Valero R; Moulin P
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1332-e1342. PubMed ID: 33221907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE PREVALENCE OF PROBABLE FAMILIAL CHYLOMICRONEMIA SYNDROME IN A SOUTHERN CALIFORNIA POPULATION.
    Tripathi M; Wong A; Solomon V; Yassine HN
    Endocr Pract; 2021 Jan; 27(1):71-76. PubMed ID: 33475504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia.
    Guay SP; Paquette M; Taschereau A; Girard L; Desgagné V; Bouchard L; Bernard S; Baass A
    Atherosclerosis; 2024 May; 392():117489. PubMed ID: 38448342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Alcoholic Fatty Liver in Patients with Chylomicronemia.
    Maltais M; Brisson D; Gaudet D
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33572376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".
    Moulin P; Dufour R; Averna M; Arca M; Cefalù AB; Noto D; D'Erasmo L; Di Costanzo A; Marçais C; Alvarez-Sala Walther LA; Banach M; Borén J; Cramb R; Gouni-Berthold I; Hughes E; Johnson C; Pintó X; Reiner Ž; van Lennep JR; Soran H; Stefanutti C; Stroes E; Bruckert E
    Atherosclerosis; 2018 Aug; 275():265-272. PubMed ID: 29980054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.
    Blom DJ; O'Dea L; Digenio A; Alexander VJ; Karwatowska-Prokopczuk E; Williams KR; Hemphill L; Muñiz-Grijalvo O; Santos RD; Baum S; Witztum JL
    J Clin Lipidol; 2018; 12(5):1234-1243.e5. PubMed ID: 30318066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia.
    Baass A; Paquette M; Bernard S; Hegele RA
    J Intern Med; 2020 Apr; 287(4):340-348. PubMed ID: 31840878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chylomicronemia.
    Navarro Hermoso A; Valdivielso P
    Clin Investig Arterioscler; 2021 May; 33 Suppl 2():75-79. PubMed ID: 34006359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
    Falko JM
    Endocr Pract; 2018 Aug; 24(8):756-763. PubMed ID: 30183397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of familial chylomicronemia syndrome from the patients' perspective.
    Gelrud A; Williams KR; Hsieh A; Gwosdow AR; Gilstrap A; Brown A
    Expert Rev Cardiovasc Ther; 2017 Nov; 15(11):879-887. PubMed ID: 28847199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome.
    Rioja J; Ariza MJ; Benítez-Toledo MJ; Espíldora-Hernández J; Coca-Prieto I; Arrobas-Velilla T; Camacho A; Olivecrona G; Sánchez-Chaparro MÁ; Valdivielso P
    J Clin Lipidol; 2023; 17(2):272-280. PubMed ID: 36813655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis.
    Chyzhyk V; Brown AS
    Trends Cardiovasc Med; 2020 Feb; 30(2):80-85. PubMed ID: 31003756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volanesorsen for treatment of familial chylomicronemia syndrome.
    Lazarte J; Hegele RA
    Expert Rev Cardiovasc Ther; 2021 Aug; 19(8):685-693. PubMed ID: 34261380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion.
    Santos RD; Lorenzatti A; Corral P; Nogueira JP; Cafferata AM; Aimone D; Lourenço CM; Izar MC; Lima JG; Lottenberg AM; Alonso R; Garay K; Morales AR; Vargas-Uricoechea H; Peña CAC; Roman-González A
    J Clin Lipidol; 2021; 15(5):620-624. PubMed ID: 34920815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.